Avid Bioservices Inc. Stock News

Avid Bioservices, Inc. (NASDAQ:CDMO ) Q1 2024 Earnings Conference Call September 7, 2023 4:30 PM ET Company Participants Tim Brons - Investor Relations Nick Green - President & Chief Executive Officer

Avid Bioservices (CDMO) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to earnings of $0.04 per share a year ago.

TUSTIN, Calif., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient live

Investors did not warmly greet the latest earnings report from the contract pharmaceutical manufacturer and developer. The company flipped into the red on the bottom line, and proffered uninspiring re

Avid grew revenue in the quarter and in the year. The company reported falling earnings per share in both the quarter and the year.

Avid Bioservices, Inc. (NASDAQ:CDMO ) Q4 2023 Earnings Conference Call June 21, 2023 4:30 PM ET Company Participants Tim Brons - Investor Relations Nick Green - President and CEO Dan Hart - Chief Fina

TUSTIN, Calif., June 14, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient live

Avid Bioservices has recently completed two expansions within its mammalian cell facilities, increasing its manufacturing capacity and potential revenue generating capacity. The company is involved in

Avid Bioservices Inc. (NASDAQ: CDMO) is a contract development and manufacturing organization (CDMO) that specializes in producing monoclonal antibodies, biologics, and novel proteins for biotech, hea

Avid Bioservices' fiscal 2023 third-quarter earnings report painted an encouraging picture. Even so, the biotech's stock may be close to fair value after today's double-digit move higher.

The stock price of Avid Bioservices Inc (NASDAQ: CDMO) increased by 10.85% after hours in the most recent trading session. This is why.

Avid Bioservices, Inc. (NASDAQ:CDMO ) Q3 2023 Earnings Conference Call March 13, 2023 4:30 PM ET Company Participants Tim Brons - Investor Relations Nick Green - President and Chief Executive Officer

Avid Bioservices (CDMO) delivered earnings and revenue surprises of 275% and 5.61%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?

Correctly spotting overpriced stocks and shunning them at the right time may avoid portfolio bleeding. ILMN, LTRX, BSY and CDMO are a few such toxic stocks.

TUSTIN, Calif., March 06, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient liv